Is the business good?
How good a business is MRK?
Merck & Co. keeps 4.8% of every revenue dollar as profit after everything, against 18% for the median Drug Manufacturers - General name.
4.8%
Net margin · Drug Manufacturers - General median 18% · 12 months to Q2 2026
- Share count, year on year
- −1.7%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 46%
R&D as % of revenue
- Gross margin
- 73%
Gross margin
Details›
- Gross margin12 months to Q2 2026
- 73%
- Net margin12 months to Q2 2026
- 4.8%
- Free cash flow margin
- 24%
- R&D as % of revenue
- 46%
- Revenue, trailing twelve months
- $66.6B
- Free cash flow, trailing twelve months
- $16.1B
- Net income, trailing twelve months
- $3.17B
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Drug Manufacturers - General
Ranks #11 of 16 by Smart Score